156 related articles for article (PubMed ID: 7025776)
1. Therapy for acute and chronic hepatitis.
Dienstag JL; Isselbacher KJ
Arch Intern Med; 1981 Oct; 141(11):1419-23. PubMed ID: 7025776
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis and therapy of HBsAg positive hepatitis.
Weimar W; Schellekens H
Biomedicine; 1979 Jul; 30(3):135-8. PubMed ID: 486686
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of chronic hepatitis (author's transl)].
Auer IO
Leber Magen Darm; 1980 Oct; 10(5):251-8. PubMed ID: 6162069
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis type virus B.
Schalm SW
Hepatogastroenterology; 1984 Feb; 31(1):12-6. PubMed ID: 6199273
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of chronic hepatitis (author's transl)].
Arnold W; Meyer zum Büschenfelde KH
Leber Magen Darm; 1981 Apr; 11(2):73-80. PubMed ID: 6164895
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
Anh-Tuan N; Novák E
Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of hepatitis B. Practical implications].
Kühn HA
Schweiz Med Wochenschr; 1977 Apr; 107(15):514-20. PubMed ID: 857309
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic approaches to chronic hepatitis B.
Smith CI; Merigan TC
Prog Liver Dis; 1982; 7():481-94. PubMed ID: 6180455
[No Abstract] [Full Text] [Related]
9. [Management of chronic hepatitis B].
Telegdy L
Orv Hetil; 1997 Jun; 138(22 Suppl 1):1462-5. PubMed ID: 9221375
[TBL] [Abstract][Full Text] [Related]
10. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.
Hui CK; Cheung WW; Zhang HY; Au WY; Yueng YH; Leung AY; Leung N; Luk JM; Lie AK; Kwong YL; Liang R; Lau GK
Gastroenterology; 2006 Jul; 131(1):59-68. PubMed ID: 16831590
[TBL] [Abstract][Full Text] [Related]
11. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
Giusti G; Ruggiero G; Galanti B; Piccinino F; Russo M; Galante D; Sagnelli E; Utili R; Pasquale G; Nardiello S; Aloisio V
Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
[TBL] [Abstract][Full Text] [Related]
13. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
14. Therapy for hepatitis B virus infection.
Perrillo RP; Mason AL
Gastroenterol Clin North Am; 1994 Sep; 23(3):581-601. PubMed ID: 7527374
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients.
Bell SJ; Lau A; Thompson A; Watson KJ; Demediuk B; Shaw G; Chen RY; Ayres A; Yuen L; Bartholomeusz A; Locarnini SA; Desmond PV
J Clin Virol; 2005 Feb; 32(2):122-7. PubMed ID: 15653414
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis of acute viral hepatitis B (author's transl)].
Platzer S; Auhuber I; Geir W; Judmaier G
Leber Magen Darm; 1978 Apr; 8(2):83-6. PubMed ID: 634017
[TBL] [Abstract][Full Text] [Related]
17. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus infection and the dialysis patient.
Fabrizi F; Messa P; Martin P
Semin Dial; 2008; 21(5):440-6. PubMed ID: 18397202
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of chronic active hepatitis caused by hepatitis B virus infection].
Degos F; Marcellin P; Benhamou JP
Gastroenterol Clin Biol; 1988 Nov; 12(11):845-54. PubMed ID: 2464521
[No Abstract] [Full Text] [Related]
20. The clinical and epidemiological significance of serum PreS1/anti-PreS1 in HBV infection.
Mi Z; Feng F; Zhang X; Lian Z; Wang H; Tong Y
Chin Med J (Engl); 1999 Apr; 112(4):321-4. PubMed ID: 11593530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
